Search for: "Ana Santos Rutschman"
Results 1 - 20
of 51
Sort by Relevance
|
Sort by Date
17 Apr 2024, 4:34 am
Ana Santos Rutschman, From Myriad to Moderna: The Modern Pharmaceutical Company, ___ Texas A&M University Journal of Property Law ___ (2024) (forthcoming). [read post]
20 Sep 2023, 1:30 pm
By Ana Santos Rutschman What can the New York City Marathon experience teach those reflecting on ways to increase equity in the transnational allocation of scarce vaccine doses? [read post]
28 Aug 2023, 2:00 am
Yaniv Heled (Georgia State University), Liza Vertinsky (University of Maryland), Ana Santos Rutschman (Villanova University), A Theory of Genetic Dimensions in the Law, 99 Ind. [read post]
15 May 2023, 2:00 am
Ana Santos Rutschman (Villanova University), Foreword: Probing the Intersection of Climate Change and Public Health, Saint Louis U. [read post]
12 May 2023, 2:00 am
Ana Santos Rutschman (Villanova University), Foreword: Probing the Intersection of Climate Change and Public Health, Saint Louis U. [read post]
30 Mar 2023, 8:15 am
.), with introductory note by Pablo Arrocha Olabuenaga Ministerial Decision on the Trips Agreement (WTO), with introductory note by Ana Santos Rutschman Documents on Russia's Exclusion from Council Eur. [read post]
27 Jan 2023, 2:00 am
Ana Santos Rutschman (Villanova University), Vaccine Contracts in the Context of Pandemics and Epidemics, N.Y.U. [read post]
11 Nov 2022, 9:06 pm
In an article published in the Journal of Law and Innovation, Ana Santos Rutschman of Villanova University Charles Widger School of Law discusses the role of algorithms in the regulation of misinformation on social media platforms. [read post]
15 Jul 2022, 9:05 pm
In an article in the Food and Drug Law Journal, Yaniv Heled of Georgia State University College of Law, Ana Santos Rutschman of Saint Louis University School of Law, and Liza Vertinsky of Emory University School of Law claim that public health emergencies require regulatory agencies, including FDA and the Centers for Disease Control and Prevention (CDC), to engage in evidence-based decision-making. [read post]
10 Jun 2022, 2:00 am
Sapna Kumar (University of Houston), Ana Santos Rutschman (Saint Louis University), Planning for Pandemic and Epidemic-Related Drug Scarcity in Intellectual Property, COVID-19, and the Next Pandemic: Diagnosing Problems, Developing Cures (Haochen Sun & Madhavi Sunder, eds. 2023): The COVID-19 pandemic... [read post]
27 May 2022, 2:00 am
Ana Santos Rutschman (Saint Louis University), Vaccine Hesitancy Across Time: Legal and Policy Interventions from the Dawn of the Anti-Vaccination Movement to the Era of Social Media, 23 N.C. [read post]
28 Apr 2022, 2:00 am
Ana Santos Rutschman (Saint Louis University), Ruqaiijah Yearby (Saint Louis University), Public Health Law and Policy in the Wake of NFIB v. [read post]
27 Apr 2022, 4:30 am
Ana Santos Rutschman (Saint Louis University - School of Law) has posted Vaccine Hesitancy Across Time: Legal and Policy Interventions from the Dawn of the Anti-Vaccination Movement to the Era of Social Media (North Carolina Journal of Law and Technology, Vol. 23, No. 3, 2022) on SSRN. [read post]
19 Nov 2021, 7:26 pm
Ana Santos Rutschman at Saint Louis University Law School has authored an interesting short article titled, "Why Moderna Won't Share Rights to the COVID-19 Vaccine with the Government that Paid for Its Development" in The Conversation. [read post]
22 Oct 2021, 2:00 am
Yaniv Heled (Georgia State University), Ana Santos Rutschman (Saint Louis University), Liza Vertinsky (Emory University), Regulatory Reactivity in FDA's Approval of the Alzheimer's Disease Drug Aducanumab (Aduhelm), Regul. [read post]
12 Oct 2021, 2:00 am
Yaniv Heled (Georgia State University), Ana Santos Rutschman (Saint Louis University), Liza Vertinsky (Emory University), An Institutional Solution to Build Trust in Pandemic Vaccines, 31 Harv. [read post]
25 May 2021, 2:00 am
Ana Santos Rutschman (Saint Louis University), Julia Barnes-Weise, The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal, Bill of Health (2021): As the toll of COVID-19 continues to increase in many countries in the Global South, there... [read post]
10 May 2021, 1:33 am
Registration is available here.The Centre for Intellectual Property Policy & Management at Bournemouth University will host a webinar on 19 May featuring Ana Santos Rutschman, who is currently Adviser for the Joe Biden’s administration as part of the COVID-19 Response Committee, on 'The IP of COVID-19'. [read post]
13 Apr 2021, 2:39 am
Professor Jens Hemmingsen Schovsbo (University of Copenhagen), president of ATRIP and IPKat friend informed us of two very interesting upcoming webinars under the theme: “IPR in times of crisis: Thoughts from the ATRIP-bubbles” 1st WEBINAR: May 20th 2021, 4pm - 7pm (Copenhagen time) Ansgar Ohly, Professor at Ludwig Maximilian University of Munich: "Patents and proportionality: a European perspective"Comments: Ana Santos… [read post]
4 Mar 2021, 10:50 am
Professor Ana Santos Rutschman lists “outbreak unpredictability, pathogen mutation, and disease complexity”—“coupled with the fact that outbreak markets have historically emerged in economically challenged areas”—as contributing factors to the lack of private-sector investment in vaccine preparedness for epidemic illnesses. [read post]
